HAE · Haemonetics Corp
United States · RS rating 98 · As of 2026-11-03
| Price | 120.28 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 89 / 94 / 96 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 53 / 77 / 72 |
| Industry group (rank) | Medical-Systems/Equip (86) |
| EPS growth Q/Q | +17.3% |
| Sales growth Q/Q | +3.6% |
| Distance from 52-week high | +1.5% |
| Market cap (USD) | $2.8B |